The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective
Thrombosis and Haemostasis · 2024-12 · 124 (12) · 1087-1094
DOI: 10.1055/a-2434-9244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 24.10.2024. Verfasst von Tatjana Potpara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, University of Belgrade, Belgrade, Serbia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiology, Practice Guidelines as Topic, Guideline Adherence. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Atrial fibrillation (AF) is a complex disease requiring a multidomain and (usually) long-term management, thus posing a significant burden to patients with AF, practitioners, and health care system. Unlike cardiovascular conditions with a narrow referral pathway (e.g., acute coronary syndrome), AF may be first detected by a wide range of specialties (often noncardiology) or a general practitioner. Since timely initiated optimal management is essential for the prevention of AF-related complications, a concise and simple guidance is essential for practitioners managing AF patients, regardless of their specialty. Guideline-adherent management of patients with AF has been shown to translate to improved patient outcomes compared with guideline-nonadherent treatment. To facilitate guideline implementation in routine clinical practice, a good guideline document on AF should introduce only evidence-based new recommendations, while avoiding arbitrary changes, which may be confusing to practitioners. Herein, we discuss the main changes in the 2024 European Society of Cardiology (ESC) AF Guidelines relative to the previous 2020 ESC document. Whether the updates and new recommendations issued by the new guidelines will translate in high adherence in clinical practice (and hence improved prognosis of patients with AF) will need to be addressed in upcoming years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Faculty, University of Belgrade, Belgrade, Serbia.
- Intensive Care for Arrhythmias, Cardiology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia.
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
- Clinic for Electrophysiology, Herz-und Diabeteszentrum NRW, Ruhr-Universität Bochum, Med. Fakultät OWL (Universität Bielefeld), Bad Oeynhausen, Germany.
ORCID-Profile: Tatjana Potpara, Giulio F Romiti
Zitieren
APA
Potpara, T., Romiti, G. F., & Sohns, C. (2024). The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective. Thrombosis and Haemostasis, 124(12), 1087-1094. https://doi.org/10.1055/a-2434-9244
Vancouver
Potpara T, Romiti GF, Sohns C. The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective. Thrombosis and Haemostasis. 2024;124(12):1087-1094. doi:10.1055/a-2434-9244
BibTeX
@article{Potpara2024,
author = {Potpara, Tatjana and Romiti, Giulio F and Sohns, Christian},
title = {The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {12},
pages = {1087--1094},
doi = {10.1055/a-2434-9244}
}
EUVIMED